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Millions of people around the world are 
exposed to high concentrations of arsenic (As) 
in drinking water, and these exposures are 
associated with a number of adverse health 
effects (International Agency for Research 
on Cancer 2004; National Research Council 
2001). There is a marked individual variabil-
ity in As metabolism, as measured by the dis-
tribution of inorganic As (iAs) and the main 
methylated metabolites mono  methylarsonic 
acid (MMA) and dimethyl  arsinic acid (DMA) 
in urine (Vahter 2002). Several studies have 
shown an association between an increased 
fraction of MMA in urine, probably reflecting 
the highly toxic MMAIII in the tissues, and an 
increased risk of various As-related adverse 
health effects (Chen et al. 2005; Chung et al. 
2009; Lindberg et al. 2008; Tseng 2007). As 
is metabolized by a series of reduction and 
methylation reactions. S-Adenosyl methio-
nine (SAM) is the main methyl donor, 
implying that As methyla  tion is dependent 
on factors influencing one-carbon metabo-
lism (Vahter 2002). As(+III oxidation state) 
methyltransferase (AS3MT) methylates As 
(Lin et al. 2002). We previously reported 
an unusual metabolism of As in a mainly 
indigenous population in the Argentinean 
Andes, with a lower percentage of MMA and 
a higher percentage of DMA compared with 
most other populations (Vahter et al. 1995). 
This is thought to be partly due to their 
high frequencies of AS3MT alleles associated 
with a lower percentage of MMA (%MMA) 
and higher percentage of DMA (%DMA) 
(Schläwicke Engström et al. 2007, 2009). 
The importance of AS3MT polymorphisms 
for As metabolism has also been also empha-
sized in other studies, both for non    coding 
variants (Agusa et al. 2009; Meza et al. 2005; 
Valenzuela et al. 2009) and for the exonic 
variant Met287Thr (Hernandez et al. 2008; 
Lindberg et al. 2007b; Valenzuela et al. 2009). 
However, there are few data on influential 
genetic variants in Bangladesh, where about 
50 million people drink water with elevated 
As concentrations and where the inhabitants 
have shown an efficient methylation of As to 
DMA, despite prevalent mal  nutrition, which 
is likely to impair one-carbon metabo  lism (Li 
et al. 2008). Functional data for AS3MT poly-
morphisms are scarce, apart from a few stud-
ies on the Met287Thr variant (Drobna et al. 
2004; Wood et al. 2006). Polymorphisms in 
the promoter and intronic regions may affect 
the expression of the AS3MT gene, which in 
turn is likely to affect the metabolite pattern.
The methylation of As may partly be 
an AS3MT-independent process, because 
methylated As species have been found in 
As3mt-knockout mice, albeit a lower frac-
tion than found in As3mt wild-type mice 
(Drobna et al. 2009). This may be explained 
by an As-methylating capacity of other 
methyl  transferases. Such candidates could 
be the DNA methyl  transferases (DNMT1a, 
DNMT3b). DNMTs and AS3MT use SAM 
as a methyl donor, and there are several paral-
lel characteristics of As methylation and DNA 
methylation (Vahter 2007).
Several different enzymes are involved 
in  the  one-carbon  metabolism  that 
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ba c K g R O u n d: Arsenic (As) occurs as monomethylarsonic acid (MMA) and dimethyl  arsinic acid 
(DMA) in humans, and the methylation pattern demonstrates large inter    individual differences. The 
fraction of urinary MMA is a marker for susceptibility to As-related diseases.
Objectives: We evaluated the impact of polymorphisms in five methyltransferase genes on As 
metabolism in two populations, one in South America and one in Southeast Asia. The methyltrans-
ferase genes were arsenic(+III oxidation state) methyltransferase (AS3MT), DNA-methyltransferase 
1a and 3b (DNMT1a and DNMT3b, respectively), phosphatidyl  ethanolamine N-methyltransferase 
(PEMT), and betaine-homocysteine methyltransferase (BHMT). AS3MT expression was analyzed 
in peripheral blood.
Me t h O d s : Subjects were women exposed to As in drinking water in the Argentinean Andes 
[n = 172; median total urinary As (U-As), 200 μg/L] and in rural Bangladesh (n = 361; U-As, 
100 μg/L; all in early pregnancy). Urinary As metabolites were measured by high-pressure liquid 
chromatography/inductively coupled plasma mass spectrometry. Polymorphisms (n = 22) were gen-
otyped with Sequenom, and AS3MT expression was meas  ured by quantitative real-time polymerase 
chain reaction using TaqMan expression assays.
Re s u l t s: Six AS3MT polymorphisms were significantly associated with As metabolite patterns in 
both populations (p ≤ 0.01). The most frequent AS3MT haplotype in Bangladesh was associated 
with a higher percentage of MMA (%MMA), and the most frequent haplo  type in Argentina was 
associated with a lower %MMA and a higher percentage of DMA. Four polymorphisms in the 
DNMT genes were associated with metabolite patterns in Bangladesh. Noncoding AS3MT poly-
morphisms affected gene expression of AS3MT in peripheral blood, demonstrating that one func-
tional impact of AS3MT poly  morphisms may be altered levels of gene expression.
cO n c l u s i O n s: Polymorphisms in AS3MT significantly predicted As metabolism across these two 
very different populations, suggesting that AS3MT may have an impact on As metabolite patterns 
in populations worldwide.
Key  w O R d s : arsenic, AS3MT, BHMT, DNMT1a, DNMT3b, gene expression, methyla-
tion, one-carbon metabolism, PEMT, polymorphism. Environ Health Perspect 119:182–188 
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generates SAM. For example, the phosphatidyl-
ethanolamine N-methyltransferase (PEMT) 
and betaine-homocysteine methyltransferase 
(BHMT) may influence As metabolism either 
by regulating the efficiency of the one carbon 
metabolism or by direct methylation of As.
In this study, we evaluated the impact 
of polymorphisms in the above-mentioned 
methyltransferases (AS3MT, DNMT1a, 
DNMT3b, PEMT, and BHMT) on As 
metabo  lism in two different female popu-
lations: in the Andean part of northern 
Argentina and in rural Bangladesh. Both 
populations are known to have a wide range 
of exposure to As in drinking water (Concha 
et al. 2006; Schläwicke Engström et al. 2007; 
Vahter et al. 2006), and both populations 
show efficient methylation of As (Li et al. 
2008; Vahter et al. 1995). Furthermore, we 
investigated the association between AS3MT 
polymorphisms and AS3MT gene expression 
in peripheral blood (Argentina), and the asso-
ciation between AS3MT gene expression and 
As metabolite pattern.
Materials and Methods
Study areas and populations. The study 
partici  pants in Argentina were mainly women 
from San Antonio de los Cobres (SAC), a vil-
lage in the northern Argentinean Andes. All 
subjects in SAC consumed drinking water 
from the same source; this water contained 
about 200 µg As/L, with small variations 
over time (Concha et al. 2006). To achieve 
a wider range of exposure, we also included 
in the study women from three nearby vil-
lages: Tolar Grande (3.5 µg As/L in drinking 
water; n = 21), Olacapato (12 µg As/L; n = 9), 
and Salar de Pocitos (73 µg As/L; n = 5). The 
study subjects in these three villages were very 
similar to the study subjects from SAC regard-
ing ethnicity and socio  economic factors. In 
total, urine and blood samples were collected 
from 176 women (not first-degree relatives) 
in 2008 (172 of which had both metabolite 
and genotyping data). The samples did not 
overlap with the women from the same region 
included in our earlier studies (Schläwicke 
Engström et al. 2007, 2009).
The Bangladeshi women studied were 
from a longitudinal mother–child study of 
As-related health effects in Matlab, a rural 
area 53 km southeast of Dhaka. This study 
group is part of a large, population-based, 
randomized food and micro  nutrient supple-
mentation trial in pregnancy (Maternal and 
Infant Nutrition Interventions in Matlab 
MINIMat). The study group and sampling 
procedures were described in detail by Li et al. 
(2008) and Vahter et al. (2006). Urine and 
blood were sampled in early pregnancy, urine 
during gestational week 8, and blood during 
gestational week 14, on average. From the 
2,119 women who were enrolled during 2002, 
500 women were randomly chosen for the 
present study. In total, 440 of the 500 women 
remained in the trial to receive micro  nutrient 
supplementation (no supplementation had 
been received before the sampling of urine), 
and 408 of those women provided a blood 
sample. Of these, urine for gestational week 8 
was available for 361 individuals.
The Ethical Review Committee of the 
International Centre for Diarrhoeal Disease 
Research, Bangladesh; the Health Ministry of 
Salta (Argentina); and the Ethics Committee 
of the Karolinska Institutet (Sweden) approved 
this study. Oral and written informed consent 
regarding sample collection was obtained from 
all participants in Argentina and Bangladesh. 
The results of the present study were evaluated 
blind for the individuals’ identity, and none of 
the participants will receive feedback regarding 
their own results.
Assessment of As exposure. Exposure to iAs 
was assessed by the total concentration of As 
metabolites in urine (U-As; sum of iAs, MMA, 
and DMA). Speciation of As metabolites in 
urine was performed using high-pressure liq-
uid chromatography (HPLC) hyphenated with 
hydride generation and inductively coupled 
plasma mass spectrometry (ICPMS) (Agilent 
1100 series system, Agilent 7500ce; Agilent 
Technologies, Tokyo, Japan, and Waldbronn, 
Germany), employing adequate quality control 
(Lindberg et al. 2007a; Schläwicke Engström 
et al. 2007). As concentrations were adjusted 
to the mean specific gravity for each popu-
lation (1.020 g/mL in Argentina and 1.012 
g/mL in Bangladesh), measured by a hand 
refractometer (Atago, Tokyo, Japan). 
Genotyping. DNA was isolated from 
peripheral blood samples from both groups 
of subjects, and geno  typing was performed 
by Swegene’s DNA Facility at Malmö 
University Hospital (Malmö, Sweden) using 
Sequenom technology (San Diego, CA, 
USA). Genotyped polymorphisms (22 poly-
morphisms in five methyl  transferases) are 
shown in Supplemental Material, Table 1 
(doi:10.1289/ehp.1002471).
Gene expression. We analyzed expression 
of the AS3MT gene (which covers 11 exons) 
by quantitative real-time polymerase chain 
reaction (qPCR) assays in peripheral blood 
samples from participants in Argentina. The 
rationale for the gene expression analyses was to 
evaluate whether the AS3MT polymorphisms 
affected gene expression, and if their possible 
effect on gene expression was due to alterna-
tive splicing of AS3MT. To evaluate potential 
alternative splicing, we ran qPCR assays for 
four different gene segments. If there was an 
alternative splicing of the gene, we assumed 
that the polymorphism that was closest to 
the amplified region was more likely to have 
an effect on the splicing of the nearby seg-
ments than those situated farther from the 
amplified region. The assays covered segments 
near the polymorphisms rs3740400 [assay 1: 
Taqman assay Hs00960536_g1, exons 1–2; 
polymorphism numbers from the National 
Center for Biotechnology Information (NCBI 
2010b)], rs3740393 (assay 2: Hs00960529_
m1, exons 5–6), and rs3740390 (assay 3: 
Hs00960532_g1, exons 8–9; all from Applied 
Biosystems, Foster City, CA, USA) and poly-
morphism rs1046778 [assay 4: 3´ untranslated 
region, base pairs 37,166–37,264 in AY817668 
(NCBI 2010a)], using Applied Biosystems’ 
Assays-by-Design. We also evaluated whether 
AS3MT polymorphisms were associated 
with the expression of cyclin M2 (CNNM2; 
Hs00929648_m1, exons 1–2), which is located 
16,500 base pairs from the AS3MT 3´ end, 
with rs1046778 as the closest polymorphism.
For each gene expression assay, we tested 
associations with the genotype of the closest 
polymorphism in subsets of the total popu-
la  tion that included approximately equal 
numbers of women with each of the three pos-
sible genotypes for that polymorphism [n per 
assay = 27–29; matched on a group level for 
age, weight, body mass index (BMI), U-As, 
and %MMA]. We repeated the analysis of 
assay 4 on a larger number of subjects with 
samples available, matched for age, weight, 
BMI, and U-As (n = 55). Peripheral blood 
was collected in PAX tubes (PreAnalytiX 
GmbH, Hombrechtikon, Switzerland), and 
all samples were frozen and stored at –20°C, 
after no more than 24 hr at room tempera-
ture after sampling. RNA was extracted with 
the PAXgene Blood RNA Kit (PreAnalytiX) 
and stored at –80°C. RNA concentration and 
purity were evaluated on a NanoDrop spectro-
photometer (Thermo Scientific, Wilmington, 
DE, USA; for all samples, 260/280 nm mean 
optical density ratio = 2.3; range, 1.7–3.3), 
and RNA integrity (RIN) was evaluated on 
a Bioanalyzer 2100 (Agilent, Santa Clara, 
CA, USA; for 17 samples, mean RIN = 8.5; 
range, 7.6–9.1). For reverse transcription, 
we used the High Capacity RNA-to-cDNA 
Kit (Applied Biosystems). Preamplification 
for AS3MT was performed before qPCR 
using TaqMan PreAmp MasterMix (Applied 
Biosystems). AS3MT expression was nor-
malized to hypo  xanthine phospho  ribosyl-
transferase 1 (HPRT1) and TATA-binding 
protein (TBP). HPRT1 and TBP were quan-
tified using SYBR Green PCR Master Mix 
(Applied Biosystems) in non  preamplified 
cDNA. The qPCR (20 µL reaction) was run 
under standard conditions on an ABI7900 
instrument (Applied Biosystems) and per-
formed in triplicate with a negative control 
included for each assay. Samples with an SD 
< 0.2 for the threshold cycle (CT) value were 
accepted. CT values of each sample were nor-
malized to the mean CT value of each ref-
erence gene (ΔCT = AS3MT CT – reference Engström et al.
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gene CT). The ΔCT values were converted to 
a linear form using the term 2–ΔCT. The coef-
ficients of variance for the mean CT values 
(2–CT) for all samples were 22% for HPRT1 
and 32% for TBP, and we found no differ-
ence in expression between individuals with 
high and low U-As. We reran assay 4 for the 
55 individuals to evaluate repeatability. The 
Pearson product-moment correlation coeffi-
cient (r) for the two runs was 0.99.
Statistical analyses. The study groups 
from Argentina and Bangladesh were analyzed 
separately. Deviations from Hardy-Weinberg 
equilibrium were tested using chi-square analy-
sis. We performed linkage dis  equilib  rium (LD) 
analysis using Haploview (Barrett et al. 2005). 
Haplotypes were inferred using PHASE soft-
ware (Stephens and Donnelly 2003). 
In consideration of normally distrib-
uted residuals, the percentage of iAs (%iAs), 
%MMA, and total U-As were natu  ral log 
(ln)-transformed for both study populations 
in all analy  ses. Associations between geno-
types or haplo  types (independent variables) 
and urinary As metabolites (dependent vari-
ables: %iAs, %MMA, and %DMA) were 
analyzed by one-way analysis of variance. For 
each metabolite (dependent variables), we 
used a multi  variable regression model (using 
the general linear model) that included geno-
type or haplotype (as categorical variables) and 
ln(U-As) (as a continuous and independent 
variable) to derive p-values for associations of 
Table 1. Descriptive data for the study populations.
Argentina Bangladesh
Variable n Median 90th–10th percentile n Median 90th/10th percentile
U-As (µg/L)a 172 200 27–450 361 100 21–390
iAs (%) 172 12 4.9–21 361 14 7–24
MMA (%) 172 7.9 4.6–12 361 10 5–17
DMA (%) 172 80 69–89 361 75 62–85
Age (years) 172 34 20–58 361 26 19–35
Weight (kg) 172 57 46–75 359 44 37–53
Height (cm) 172 152 145–159 361 150 144–158
BMI (kg/m2) 172 24 20–32 359 19 17–24
Parity 168 3 1–8 360 1 0–4
Coca use (%) 172 46  NA
NA, not applicable. 





n %iAs %MMA %DMA n %iAs %MMA %DMA
AS3MT
rs7085104
GG 93 9.6 7.1 81.2 30 13.7 9.7 74.5
GA 62 11.7 8.6 77.6 147 13.7 10.2 73.5
AA 15 14.2 10.3 73.5 182 13.4 9.5 74.3
p-Value 1c 0.03 0.001 0.001 0.89 0.14 0.58
p-Value 2d 0.051 0.002 0.002 0.85 0.14 0.58
rs3740400e 
CC 93 9.6 7.1 81.2 71 14.1 8.8 74
CA 61 11.8 8.5 77.5 180 13.6 10.2 73.7
AA 15 14.2 10.3 73.5 103 13.3 9.7 74.6
p-Value 1 0.027 0.001 < 0.001 0.74 0.008 0.51
p-Value 2 0.058 0.003 0.003 0.73 0.008 0.51
rs3740393f 
CC 85 9.2 6.9 81.9 13 10.8 7.9 79.8
GC 68 12 8.7 77.2 105 12 9.2 76.8
GG 17 14.7 10 73.3 240 14.5 10.1 72.5
p-Value 1 0.003 < 0.001 < 0.001 0.003 0.13 0.001
p-Value 2 0.007 0.001 < 0.001 0.003 0.13 0.001
rs3740390f
AA 84 9.3 6.9 81.8 11 11.3 7.8 79.4
AG 69 11.9 8.7 77.4 94 12.2 9.4 76.5
GG 17 14.7 10 73.2 255 14.2 10 72.9
p-Value 1 0.006 < 0.001 < 0.001 0.025 0.15 0.004
p-Value 2 0.018 0.001 < 0.001 0.034 0.15 0.005
rs11191439
MetMet 163 10.7 7.8 79.4 313 13.2 9.7 74.6
MetThr 6 12.6 10.2 75.5 42 16.7 11 69
p-Value 1 0.86 0.22 0.45 0.004 0.086 < 0.001
p-Value 2 0.67 0.1 0.26 0.005 0.086 0.001
rs11191453f
CC 83 9.3 6.9 81.9 11 11.3 7.8 79.4
CT 71 12 8.7 77.3 93 12.2 9.6 76.3
TT 17 14.7 10 73.3 250 14.3 10 72.8
p-Value 1 0.004 < 0.001 < 0.001 0.015 0.17 0.004





n %iAs %MMA %DMA n %iAs %MMA %DMA
rs10748835e
AA 93 9.6 7.1 81.3 67 14.4 8.5 73.9
AG 62 12 8.6 77.3 189 13.2 10.2 74.2
GG 15 14.2 10.3 73.5 95 14.1 10 73.4
p-Value 1 0.014 0.001 < 0.001 0.38 0.001 0.94
p-Value 2 0.035 0.001 0.002 0.39 0.001 0.97
rs1046778e
CC 87 9.3 6.9 81.9 45 13.1 7.9 76.5
CT 69 12.1 8.7 77.2 183 13.1 9.6 74.6
TT 15 14.2 10.3 73.5 132 14.3 10.7 72.4
p-Value 1 0.005 < 0.001 < 0.001 0.38 < 0.001 0.052
p-Value 2 0.013 < 0.001 < 0.001 0.4 < 0.001 0.083
DNMT1a
rs2228612 (in LD with rs10845076)
GG 21 12.7 7.5 77.1 20 11.9 9.9 76.7
GA 62 9.8 7.8 80.4 123 13 9.7 74.6
AA 88 11 8 78.9 217 14 9.8 73.5
p-Value 1 0.13 0.88 0.17 0.17 0.89 0.42
p-Value 2 0.17 0.9 0.23 0.028 0.89 0.4
DNMT3b
rs6087990
TT — 34 13.7 10.6 73.8
TC 19 12.1 8.6 76.9 145 12.5 9.8 75.8
CC 150 10.5 7.8 79.6 180 14.5 9.7 72.6
p-Value 1 0.12 0.12 0.059 0.015 0.33 0.007
p-Value 2 0.32 0.099 0.12 0.030 0.33 0.013
rs2424913
CC — 26 12.5 10.2 75.5
CT 17 11.7 8 78 133 12.6 9.8 75.6
TT 153 10.6 7.8 79.4 200 14.3 9.7 72.8
p-Value 1 0.24 0.49 0.25 0.037 0.64 0.020
p-Value 2 0.45 0.48 0.42 0.044 0.64 0.021
Table 2. Observed mean valuesa for As metabolites according to genotype for polymorphisms that were significant predictors of As metabolites in the   regression 
models.
a%iAs and %MMA are both geometric means, whereas the %DMA is an arithmetic mean. bThe AS3MT genotype associated with a low %MMA and a high %DMA in Argentina is 
listed first. cp-Value 1 for genotype coefficients (coded as categorical variables according to the number of variant alleles) from multivariate regression models for each population 
and outcome [ln(%iAs), ln(%MMA), or %DMA in Argentina or Bangladesh] adjusted for ln(U-As) only; the models were not used to derive mean values for the metabolites. dp-Value 2 
for genotype coefficients (coded as categorical variables) from multivariate regression models for each location and outcome with adjustment for ln(U-As) and the following covari-
ates: for Argentina ln(%iAs): coca use, age, parity; Argentina ln(%MMA): coca use, BMI, parity; Argentina %DMA: coca use, BMI, age, parity; Bangladesh ln(%iAs) and %DMA: age, 
BMI. Models used to test associations with ln(%MMA) in Bangladesh were adjusted for ln(U-As) only because none of the other variables tested had a p < 0.2 in the univariate model. 
Models were used for hypothesis testing only and were not used to derive mean values for the metabolites. ePoly  morphisms in AS3MT LD cluster # 1 in Bangladesh. fPolymorphisms in 
LD cluster # 2. AS3MT polymorphisms and AS3MT gene expression
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geno  types or haplo  types with each metabo  lite. 
Additionally, for each metabolite, we used a 
multi  variable regression model that included 
genotype or haplotype, ln(U-As), and adjust-
ments for other variables. For each metabolite, 
all potentially influential independent variables 
were tested in uni  variate analyses, and those 
with p < 0.2 were included in the latter multi-
variable regression model. The potentially 
influential variables tested for the Argentinean 
study group were body weight, BMI, age, 
parity (all modeled as continuous variables), 
and coca use (yes/no), whereas those for the 
Bangladeshi study group were gestational 
week, body weight, BMI, age, and parity (all 
modeled as continuous variables).
Each polymorphism was modeled as a 
cate  gorical variable (zero, one, or two alleles). 
When the frequency of a homo  zygous geno-
type was very low (one to three individuals), 
the group was pooled with the hetero  zygotes. 
Haplotypes were also modeled as cate  gorical 
variables (zero, one, or two copies of the hap-
lotype). The genotype or haplotype associated 
with a low %MMA and a high %DMA was 
used as the reference geno  type, because the aim 
was to discover which genotypes are associated 
with high fractions of MMA, a risk factor for 
As-related health effects. Observed geometric 
or arithmetic mean percent metabolite values 
are reported according to genotype for poly-
morphisms that were significantly associated 
with one or more metabolites (p < 0.05) in 
models adjusted for ln(U-As) only or in mod-
els adjusted for ln(U-As) and other variables. 
Observed geometric or arithmetic mean per-
cent metabolite values are also reported for 
the most common AS3MT haplotypes. We 
used models for hypothesis testing only, and 
no model-based estimates are reported.
We evaluated associations of AS3MT geno-
type with AS3MT gene expression using the 
non  parametric Kruskal-Wallis test. The asso-
ciation between gene expression in assay 4 and 
As the metabo  lite pattern in urine was evalu-
ated using Spearman’s rank correlation coef-
ficient (rs).
All statistical analyses were performed 
using SPSS (version 17; SPSS Inc., Chicago, 
IL, USA). We considered p < 0.05 to be sta-
tistically significant. 
Results
General characteristics. All polymorphisms 
were in Hardy-Weinberg equilibrium except for 
DNMT1a rs2228611 in Argentina (χ2 = 4.9, 
p = 0.03; in Bangladesh, χ2 = 0.4, p 0.52).
Descriptive data for both study groups 
are presented in Table 1. No smokers were 
included in the study groups. Compared with 
women in Bangladesh, women in Argentina had 
U-As about twice as high (median, 200 µg/L; 
Bangladesh median, 100), lower %MMA 
(7.9% vs. 10%), and higher %DMA (80 vs. 
75%). The U-As range was wide in both popu-
lations (10–1,200 in Argentina; 5–1,200 in 
Bangladesh).
AS3MT genotype analysis. The seven non-
coding AS3MT polymorphisms had completely 
different allelic frequencies in the two study 
groups [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002471)]. In Argentina, 
all AS3MT polymorphisms, except for 
rs11191439 (Met287Thr), showed strong LD 
(R2 between 0.82 and 0.98; see Supplemental 
Material, Figure 1). In Bangladesh, we detected 
two LD clusters: one cluster with rs3740400, 
rs10748835, and rs1046778 (cluster 1) and 
one cluster with rs3740393, rs3740390, and 
rs11191453 (cluster # 2) (see Supplemental 
Material, Figure 1). The polymorphism 
rs11191439 showed no LD with any of the 
other AS3MT polymorphisms evaluated in 
either study popu  lation.
In Argentina, all AS3MT polymorphisms, 
except for the non  synonymous rs11191439, 
were significantly associated with the 
metabo  lite pattern, and for each polymor-
phism the allele associated with lower %iAs, 
lower %MMA, and higher %DMA was the 
most common (Table 2). In Bangladesh, all 
AS3MT polymorphisms except rs7085104 
were significantly associated with the metabo-
lite pattern. However, patterns of associa-
tions varied between the two LD clusters: 
Polymorphisms in cluster 1 were significantly 
associated with %MMA but not %iAs or 
%DMA, whereas polymorphisms in cluster 2 
were significantly associated with %iAs and 
%DMA but not %MMA. In most cases, the 
alleles associated with lower %MMA or lower 
%iAs and higher %DMA were the less fre-
quent ones in Bangladesh.
In both populations, participants pos-
sessing one or two copies of haplotype 1 had 
higher %MMA than did those who did not 
carry this haplotype (Table 3). Haplotype 1 
was  the  most  common  haplotype  in 
Bangladesh (52%). Haplotype 2 was associ-
ated with lower %iAs, lower %MMA, and 
higher %DMA in both populations (although 
Table 3. Observed percentages of As metabolites according to copy number (zero, one, or two) of the common AS3MT haplotypes.
Argentina Bangladesh
Haplotype/sequencea 0 copies 1 copy 2 copies p-Valueb 0 copies 1 copy 2 copies p-Valueb
1. AAGGTTGT
n (%) 97 (57) 60 (35) 15 (9) 79 (22) 192 (53) 90 (25)
Geometric mean %iAs 9.5 11.9 14.2 0.015 14.1 13.2 14.0 0.66
Geometric mean %MMA 7.1 8.6 10.3 0.001 8.7 10.2 10.0 0.006
Mean %DMA 81.4 77.5 73.5 < 0.001 74.1 74.2 73.6 0.97
2. GCCATCAC
n (%) 17 (10) 71 (41) 84 (49) 255 (71) 95 (26) 11 (3)
Geometric mean %iAs 14.7 12.0 9.0 0.001 14.2 12.2 11.3 0.027
Geometric mean %MMA 10.0 8.7 6.8 < 0.001 10.0 9.5 7.8 0.16
Mean %DMA 73.3 77.3 82.2 < 0.001 72.9 76.4 79.4 0.005
3. ACGGTTAC
n (%) 171 (99.4) 1 (0.6) — 250 (69) 104 (29) 7 (2)
Geometric mean %iAs NA NA — NA 13.3 14.3 11.4 0.16
Geometric mean %MMA NA NA — NA 10.3 8.7 8.0 < 0.001
Mean %DMA NA NA — NA 74.2 73.4 78.7 0.16
4. GCGGCTAT
n (%) 166 (96) 6 (4) — 322 (89) 39 (11) —
Geometric mean %iAs 10.7 12.6 — 0.27 13.2 17.1 — 0.002
Geometric mean %MMA 7.7 10.2 — 0.27 9.6 11.1 — 0.088
Mean %DMA 79.4 75.4 — 0.45 74.7 68.2 — < 0.001
Abbreviations: n, number of individuals; NA, not applicable (no or very few individuals with that haplotype).
aPolymorphisms are listed in 5´ to 3´ direction: rs7085104, rs3740400, rs3740393, rs3740390, rs11191439, rs11191453, rs10748835, and rs1046778. Only haplotypes with a frequency > 5% 
in any population are included; for individuals with missing data for one or more polymorphisms, the missing alleles were inferred using PHASE. bp-Values for haplotype coefficients 
(coded as categorical variables according to the number of copies of the haplotype) from regression models for each population and outcome [ln(%iAs), ln(%MMA), or %DMA in 
Argentina or Bangladesh] adjusted for ln(U-As) only. The models were not used to derive mean values for the metabolite; models with adjustments for other influential variables (see 
information for p-value 2 Table 2 footnote d) were also evaluated, but the p-values were very similar when adjusting for ln(U-As) only (data not shown).Engström et al.
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%MMA was not statistically significant 
in Bangladesh) and was more frequent in 
Argentina (70%) than in Bangladesh (16.5%). 
Haplotype 3 was significantly associated with 
lower %MMA, but this haplotype was pres-
ent almost exclusively in Bangladesh (16.5%). 
Haplotype 4 was associated with higher %iAs 
and lower %DMA in both populations, 
although this was statistically significant only 
in Bangladesh. This was the only haplotype 
containing the C-allele of rs11191439, and we 
found no individuals with two copies of this 
haplotype in either population.
AS3MT expression analysis. Heterozygous 
and homo  zygous genotypes that included 
alleles associated with high %MMA and low 
%DMA among the women in Argentina 
were associated with higher AS3MT expres-
sion than were corresponding reference 
genotypes associated with low %MMA and 
high %DMA. Associations were statistically 
significant for rs3740400 based on assay 1 
(observed gene expressions for the AA and 
CA genotypes were 240% and 220% higher, 
respectively, than for the CC genotype; 
p = 0.009) and for rs1046778 based on assay 4 
(observed gene expressions for the TT and CT 
genotypes were 69% and 36%, respectively, 
higher than for the CC genotype; p = 0.008) 
(Figure 1); the p-values for the other assays 
were 0.18 (for rs3740393 based on assay 2) 
and 0.077 (for rs3740390 based on assay 3). 
We ran both endogenous control genes for 
all assays. The results were very similar when 
using HPRT1 or TBP as endogenous controls, 
but the HPRT1 gene demonstrated less vari-
ability (the coefficient of variance was 22% 
for HPRT1 vs. 32% for TBP). We found no 
association between the AS3MT rs1046778 
polymorphism and expression of the down-
stream gene CNNM2 (p = 0.82). Carriers of 
each geno  type demon  strated a similar expres-
sion pattern for all AS3MT gene segments 
analyzed, and we found no evidence that a cer-
tain genotype caused alternative splicing. We 
repeated the gene expression analysis based on 
assay 4 on a larger set of individuals (n = 55) 
and observed the same pattern: relative to the 
rs1046778 CC genotype, AS3MT expression 
was 175% and 80% higher among those with 
rs1046778 TT and CT genotypes, respectively 
(p < 0.001; Figure 1). Among these 55 indi-
viduals, expression of AS3MT (assay 4) was 
positively (but not significantly) associated 
with %iAs (rs = 0.16, p = 0.24) and %MMA 
(rs = 0.18, p = 0.18) and inversely associated 
with %DMA (rs = –0.28, p = 0.090).
DNMT1a and DNMT3b. The minor 
allele frequencies for the five poly  morphisms 
analyzed in DNMT1a were 4–40% in 
Argentina and 2–44% in Bangladesh, whereas 
the minor allele frequencies for the three poly-
morphisms analyzed in DNMT3b were 5–6% 
in Argentina and 23–44% in Bangladesh [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002471)]. The LD pattern for the DNMT 
genes was similar in Bangladesh and Argentina. 
The rs10854076 and rs2228612 polymor-
phisms in DNMT1a showed strong LD in both 
populations (R2 = 0.99 in Argentina, 0.84 in 
Bangladesh), whereas the R2 values between the 
other polymorphisms in DNMT1a were rather 
low. All DNMT3b polymorphisms showed LD 
in both study populations, with R2 values rang-
ing from 0.39 to 0.79 in Bangladesh and from 
0.88 to 1 in Argentina.
We found no significant associations 
between DNMT polymorphisms and As 
metabolism among the Argentinean women. 
However, four DNMT polymorphisms were 
significantly associated with metabolite pat-
terns among women in Bangladesh (Table 2): 
The DNMT1a polymorphisms rs2228612 and 
rs10845076 (in complete LD) predicted %iAs 
(p = 0.028, highest for the common rs2228612 
AA variant), whereas the DNMT3b polymor-
phisms rs6087990 and rs2424913 predicted 
%iAs (p = 0.030 and 0.044, highest for the 
common rs6087990 CC and rs2424913 TT 
genotypes, respectively) and %DMA (p-val-
ues = 0.013 and 0.021, respectively, with 
lower mean values for the CC and TT geno-
types). We observed no significant associations 
with metabolite patterns in either population 
for DNMT1a rs2228611, rs16999593, or 
rs7253062 or for DNMT3b rs2424932 (data 
not shown).
PEMT  and  BHMT.  For  PEMT, 
rs1531100 and rs4244598 showed LD for 
both populations (R2 = 0.70 in Bangladesh 
and 1 in Argentina), but rs2278952 and 
rs897453 showed no LD with any other 
PEMT polymorphism evaluated. The two 
BHMT polymorphisms showed no LD. 
Polymorphisms in PEMT or BHMT were 
not statistically significant predictors of As 
metabolite patterns.
Discussion
This study demonstrated strong associations 
between AS3MT polymorphisms and As 
metabolism in two populations, one from the 
Argentinean Andes and one from Bangladesh, 
both of which are heterogeneous in genetic 
background and in living conditions. The find-
ing of two LD clusters with different patterns 
of metabolite fractions suggests the presence 
of several influential poly  morphisms along the 
gene. Non  coding poly  morphisms in AS3MT 
were significantly associated with altered gene 
expression. In addition, four polymorphisms 
in DNMT1a and DNMT3b were associated 
with As metabolites among the pregnant 
women from Bangladesh.
One strength of this study is that both 
populations had wide ranges of both total 
U-As and As metabolites. Also, the study 
subjects within each population were rather 
homogeneous regarding social status and 
food habits. However, the populations dif-
fered from each other in a number of ways, 
not only genetically but also regarding food 
habits, nutritional status, lifestyle factors, 
and pregnancy (all women from Bangladesh 
were in early pregnancy). This strengthens 
the hypothesis that the impact of AS3MT 
on As metabolite pattern should be valid for 
people worldwide and not strongly modified 
by environ  mental or biological factors.
We are aware that relatively few indi-
viduals were included in the gene expression 
analyses. Nevertheless, geno  type was highly 
predictive of the gene expression of AS3MT. 
This was apparent despite the fact that gene 
expression was meas  ured in peripheral blood, 
which has a lower expression of AS3MT than 
Figure 1. Box plots depicting relative AS3MT gene expression according to genotype in women from 
Argentina; expression for the reference genotype (associated with low %MMA and high %DMA) is set 
to 1. (A) Relative gene expression based on assay 1 (covering exons 1–2) according to rs3740400 genotype. 
(B) Relative gene expression based on assay 4 (covering part of the 3´ untranslated region) according to 
rs1046778 genotype. Numbers below the boxes indicate the number of individuals with that genotype. The 
bottom and top of each box indicate 25th and 75th percentiles, respectively; the line inside the box is the 
median; whiskers represent the smallest and the largest values that are not outliers. Circles and asterisks 
indicate outliers; squares indicate outliers outside the range of the y-axis, which had a gene expression of 
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in the main As-methylating tissues, that is, 
liver and kidney (Su et al. 2004). We used 
blood as a proxy for liver because sampling 
liver tissues is a difficult and invasive proce-
dure. It is, however, important to note that 
extrapolation of gene expression from blood 
to liver is difficult because of tissue-specific 
differences in transcription factors and other 
regulating elements, as well as differences in 
metabolite distributions between blood and 
liver, that may affect the result. 
Six polymorphisms were associated with 
As metabolite pattern in subjects from both 
Argentina and Bangladesh. Several AS3MT 
polymorphisms were associated with %iAs, 
which we did not detect in our earlier studies 
in Argentina (Schläwicke Engström et al. 2007, 
2009), possibly due to a lower power in those 
studies (which included about 100 fewer indi-
viduals). We confirmed associations between 
six AS3MT poly  morphisms and As metabo-
lism observed in our earlier studies in another 
group of individuals from the same region in 
Argentina (Schläwicke Engström et al. 2007, 
2009). Additionally, two polymorphisms 
not investigated in any of our earlier studies 
(rs11191453 and rs1046778) significantly 
predicted the metabolite pattern. Because 
many polymorphisms showed strong LD and 
because the significance levels are dependent 
on the genotype frequencies, it is not possible 
to attribute causal effects to specific variants. 
However, in Bangladesh we observed associa-
tions with %MMA mainly for polymorphisms 
in cluster 1 (rs3740400, rs10748835, and 
rs1046778), which are situated in the 5´ and 
the 3´ end of the gene, whereas we observed 
associations with %iAs and %DMA mainly 
for polymorphisms in cluster 2 (rs3740393, 
rs3740390, and rs11191453), which are situ-
ated in the middle and the 3´ end of the gene. 
We confirmed previous findings of a higher 
%MMA and lower %DMA in association with 
the Thr allele in Met287Thr (rs111191439) 
(Hernandez et al. 2008; Lindberg et al. 
2007b; Valenzuela et al. 2009). The Thr allele 
in Met287Thr has also been associated with 
a marginally higher risk (p = 0.055) of pre-
malignant skin lesions (Valenzuela et al. 2009). 
This polymorphism had rather low frequen-
cies in the populations studied, which were 
from Chile (Hernandez et al. 2008), Eastern 
Europe (Lindberg et al. 2007b), and Mexico 
(Valenzuela et al. 2009), where the allele fre-
quencies were around 5–10%.
The fact that the women from Bangladesh 
were in early pregnancy may have had an 
impact on the association between poly-
morphisms in methyl  transferases and As 
metabo  lite patterns. Pregnancy is known to 
induce methyla  tion reactions required for tis-
sue growth and development, as well as As 
methylation (Concha et al. 1998; Szyf 2009), 
which may have obscured associations with 
poly  morphisms in methyl  transferase genes 
among the women in Bangladesh. However, 
to determine the effect of pregnancy on the 
associations between geno  type and As metabo-
lite pattern, pregnant and non  pregnant women 
from the same population should be compared, 
or a study with repeated sampling during preg-
nancy could be performed.
The frequencies of the AS3MT poly-
morphisms associated with As metabolism devi-
ated markedly between the Argentinean and 
Bangladeshi populations. In the Argentinean 
population, the alleles and haplo  types asso-
ciated with more efficient methylation were 
very frequent, which is interesting considering 
the fact that the indigenous people have been 
living in this As-contaminated area for many 
generations (Figueroa et al. 1992), suggesting a 
selection for geno  types associated with efficient 
As metabolism. In Bangladesh, where most of 
the tube wells have been installed in the last 
20–40 years, the alleles associated with more 
efficient methylation were the least common; 
nevertheless, allele frequencies were rather 
high (~ 45%) for the polymorphisms in LD 
cluster 1. Still, the general evidence of asso-
ciations between AS3MT genotype on the As 
metabolite fraction was similar in both popula-
tions. The present study, as well as other stud-
ies (Agusa et al. 2009; Hernandez et al. 2008; 
Lindberg et al. 2007b; Meza et al. 2005), 
strongly support a causal association of AS3MT 
geno  type on As metabolism worldwide.
A higher %MMA is linked to several 
adverse health effects (Hsueh et al. 1997; 
Lindberg et al. 2008; Tseng 2007; Yu et al. 
2000). Individuals in Bangladesh who had an 
MMA level > 8% had a significantly higher 
risk (p < 0.01) for skin lesions compared with 
the reference group (where %MMA was < 8) 
(Lindberg et al. 2008). As demon  strated here, 
AS3MT genotypes significantly predict the 
fraction of metabolites and may explain part 
of the individual differences in the fraction of 
MMA detected and, in turn, explain differ-
ences in susceptibility to skin lesions. Thus, 
AS3MT genotype is probably a susceptibility 
factor for As toxicity, and the allelic distribu-
tion of AS3MT polymorphisms should be 
taken into account in future risk evaluations 
of As in drinking water and food.
In the present study, we demonstrate for 
the first time that non  coding AS3MT poly-
morphisms were associated with AS3MT 
gene expression levels. The common homo-
zygotes in the Argentinean population were 
associated with lower %MMA and higher 
%DMA and were also associated with lower 
AS3MT expression relative to other geno-
types. We could not determine whether asso-
ciations were causal effects due to a single 
AS3MT polymorphism or a specific hap-
lotype, because all polymorphisms, spread 
throughout the gene, showed strong LD in 
Argentina. However, poly  morphisms in the 
5´ part of the gene (assay 1, 5´ of rs3740400) 
and 3´ untranslated region (assay 4, including 
rs1046778), which are likely to involve regu-
latory sequences, were significantly associated 
with gene expression. In addition, expression 
was also associated, although not significantly, 
with metabolite patterns in urine. We saw no 
indications that the genotype influenced the 
splicing of the gene, because we observed a 
similar pattern of gene expression for all four 
gene segments analyzed.
Wood et al. (2006) evaluated the potential 
impact of polymorphisms on AS3MT protein 
levels in vitro, where the transient expression 
of the wild-type AS3MT sequence and the 
variant allozyme of Met287Thr were evaluated 
in COS-1 monkey kidney cells. Endogenous 
activity of untransfected COS-1 cells was neg-
ligible. The 287Thr allozyme, which has been 
associated with a higher %MMA and lower 
%DMA, had higher in vitro protein levels 
than did those of the wild type. In the present 
study, very few Argentinean subjects possessed 
the Thr allele, so it was not possible to evalu-
ate whether this polymorphism was associated 
with AS3MT gene expression. However, for 
the polymorphisms that we included in the 
gene expression analyses, the alleles associ-
ated with higher %MMA and lower %DMA 
were associated with higher gene expression, 
similar to the association between the 287Thr 
allele, linked to higher %MMA and lower 
%DMA, and higher in vitro protein levels. 
Gene expression and protein levels are not 
always correlated because post  transcriptional 
regulation processes may be involved. Further 
studies are needed to evaluate the impact of 
polymorphisms on the protein level.
We observed associations with DNMT 
polymorphisms in Bangladesh only, and 
these results need to be confirmed. DNMT1a 
rs16999593 was previously associated with 
lower %DMA in Argentina (Schläwicke 
Engström et al. 2009), but this association was 
not evident in the present study population. 
However, some of the DNMT polymorphisms 
had a very low allele frequency in Argentina.
Conclusions
Polymorphisms in AS3MT significantly pre-
dicted As metabolism in these two very differ-
ent populations, which suggests that an effect 
of AS3MT on As metabolite pattern may be 
present in populations worldwide. AS3MT 
polymorphisms were also associated with 
AS3MT expression in peripheral blood, such 
that polymorphisms associated with efficient 
methylation were associated with reduced 
expression of the AS3MT gene. Evidence of 
an effect of the polymorphisms is of impor-
tance for risk assessment of As, because a 
low methylation efficiency is associated with 
increased risk for As toxicity.Engström et al.
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